Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Marijuana Withdrawal and Relapse
NCT00743366Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine (extended-release tablet, brand name: Bipresso) in cannabis use disorder (CUD), sponsored by New York State Psychiatric Institute. Started Aug 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00743366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743366.